insights_auto
Por que MANKIND caiu 3,07%?
Saiba maischevron_right
MANKIND:NSE
Mankind Pharma Ltd
₹ 2.275,50
arrow_downward
-3,07%(-72,10) 1D
16 de out., 15:30:00 GMT+5:30 · INR
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para MANKIND…
Abrir
₹ 2.349,90
Alta
₹ 2.354,40
Baixa
₹ 2.268,70
Valor de mercado
937,40 bi
Volume médio
483,95 mil
Volume
889,73 mil
Índice P/L
46,04
Alto — 52 sem
₹ 2.642,00
Baixo — 52 sem
₹ 1.909,70
LPA
₹ 49,42
Nº de funcionários
20 mil
Abrir
₹ 2.349,90
Alta
₹ 2.354,40
Baixa
₹ 2.268,70
Valor de mercado
937,40 bi
Volume médio
483,95 mil
Volume
889,73 mil
Índice P/L
46,04
Alto — 52 sem
₹ 2.642,00
Baixo — 52 sem
₹ 1.909,70
LPA
₹ 49,42
Nº de funcionários
20 mil
Notícias
De fontes da web e parceiros de notícias
The Pharma Letter
·
há 7 horas
Lakefront sells CAR-T programs as Mankind agrees Armed Cell investment
Perfil
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Sobre Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Funcionários20,5 mil
Data de fundação1991
Sede-
Setor-